ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Rewiring Antitumor Immunity: Targeting CLDN18.2 with Conditional 4-1BB Activation.

Giulia Pretelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.